Загрузка...
Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment
INTRODUCTION: Lately, the use of biological therapy in various autoimmune diseases is increasing. The ideal marker for monitoring the effects of modern therapy is still non-existent. AIM: To investigate early response biomarkers of SLE and RA patients under the rituximab treatment are in research ph...
Сохранить в:
| Опубликовано в: : | Med Arch |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Academy of Medical Sciences of Bosnia and Herzegovina
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7007611/ https://ncbi.nlm.nih.gov/pubmed/32082002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5455/medarh.2019.73.374-377 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|